The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The skyrocketing demand for depression management drugs amid the COVID-19 pandemic will rapidly broaden the horizons of this market
Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/antidepressants-market-105017
Some major points from Table of Content:
· Introduction
o Market Scope
o Market Segmentation
o Market Methodology
o Definitions and Assumptions
· Executive Summary
· Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
· Key Insights
o Prevalence of Anxiety & Depression –Key Regions/Country
o New Product Launch
o Pipeline Analysis
o Impact of COVID-19 on the Market
o Key Industry Developments – Mergers, Acquisitions, and Partnerships
· Global Antidepressants Market Analysis, Insights and Forecast, 2016-2027
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Drug Class
§ Selective Serotonin Reuptake Inhibitors (SSRIs)
§ Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
§ Atypical Antidepressants
§ Tricyclic Antidepressants (TCAs)
§ Monoamine Oxidase Inhibitors (MAOIs)
§ Others
